This mechanism may be relevant to the action of the ISIS 304801 antisense oligonucleotide inhibitor of APOC3 mRNA to lower triglycerides in patients with lipoprotein lipase deficiency or hypertriglyceridemia. Here, APOC3 is linked to hypertriglyceridemia.